Forget Pfizer... Medicine's Golden Age Is Here!

Explosive change is coming and so are even more explosive gains Explosive change is coming and so are even more explosive gains                                                                                                      Wealth Daily: Fortune Favors the Bold   [Wealth Daily]      by keith kohl / december 8, 2022 Forget Pfizer... Medicine's Golden Age Is Here! Experts are calling it the Industrial Revolution for health care... And Moore’s law for medicine.The massive wave of innovation occurring throughout the sector is the dawn of medicine’s “Golden Age.”And the COVID-19 vaccines that were created in record time are just the start.What’s coming down the pike is going to be much, much bigger.According to Barron’s, "Explosive change is coming in our ability to diagnose, treat, and even cure many debilitating diseases." With a record number of investments pouring into this sector...And the biotech industry and the government working together more closely than they ever have before... We’re seeing the explosive convergence and optimization of a number of different technologies that will allow us to cure many diseases. Lifesaving medicines and treatments could get to patients much faster — and much more cheaply.We could even witness the cure for cancer... or even the cure for ALL diseases. This is why biotech is going to be the hottest place for investors to be in 2022. If you had been investing in this sector over the past year... You could have cashed in on all these huge gains: - +1,273% - +1,144% - +982% - +460% - +350% A $2,500 investment into each of those plays would have handed you $105,225 in pure profit.But I think biotech’s “Golden Age” is going to put those gains to shame.We are witnessing the "Industrial Revolution" in biotech...And it’s all starting right now. In short, if you stay OUT of the biotech market, you WILL miss life-changing gains.We’re talking about more new innovations, drugs, and therapies than ever before...That could set you up to potentially clock [massive paydays of $16,890, $43,460, and even $193,800...]( From the most lucrative and fast-paying biotech stocks in the world. And I’m not talking about multibillion-dollar giants like Pfizer, Johnson & Johnson, or Merck... But the smaller, innovative companies that are not covered by the mainstream press... The billion-dollar buyout targets for these massive, cash-rich pharmaceutical giants. [Take advantage of this now.]( To your wealth, [Keith Kohl sig]Keith KohlInvestment Director, Topline Trader [Feedback? get in touch](mailto:/newsletter@wealthdaily.com?subject=Wealth%20Daily%20feedback) [Read this email online]( [Manage Newsletters]( [Share on Twitter]( You signed up for our newsletter with the email {EMAIL}. You can manage your subscription and get our privacy policy [here](. This email is from Angel Publishing, 3 East Read Street, Baltimore, MD 21202 © Wealth Daily.  Â